Novel Coronavirus (COVID-19) Physician Tracking Report – Wave 6

Since January, InCrowd has been conducting novel coronavirus (COVID-19) tracking research to understand the impact of the pandemic on several US healthcare stakeholder groups. Now in its fifth wave, InCrowd has been monitoring frontline-treating physicians’ perceptions on the spread of the virus, preparedness, a variety of concerns, and how they envision both pharma engagement and care delivery in the future. Discover the latest findings and insights from InCrowd’s most recent wave of COVID-19 physician research.


  • Method: 12-minute MicroSurvey via InCrowd
  • Crowds: US Primary Care Physicians (PCPs), Pediatricians (PEDs), and Emergency Medicine or Critical Care Physicians (EMCCs)
  • Sample Size: n=211
  • Fielding Period: June 26, 2020 (Previous Waves: May 29-31, Apr. 14-15, Mar. 19-20, Feb. 26-27, Jan. 31-Feb. 4)

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Five Ways to Improve MedTech DTC Patient Engagement

Five Ways to Improve MedTech DTC Patient Engagement

US Patient & Physician Perspectives For this year's DTC National Conference, InCrowd wanted to demonstrate the ways in which diabetic patients perceive DTC ads for medical devices designed to help treat their condition. We also examined how treating...

read more
Pre-ASCO Excitement Report

Pre-ASCO Excitement Report

Instant Insights It’s just 3 weeks until ASCO (American Society of Clinical Oncology’s annual meeting), and oncologists have shared with us the agenda topics that most interest them. Immunotherapies topped the list, with CAR-T the most popular among them. Take a look...

read more